KCNE5

KCNE5 is an ancillary (beta) subunit that modulates the gating, current amplitude, and trafficking of multiple voltage-gated potassium channel alpha-subunits in cardiac tissue (PMID:12324418, PMID:30289750). Through specific transmembrane-domain residues, KCNE5 physically associates with KCNQ1 and dramatically right-shifts its voltage-dependent activation by more than 140 mV, slowing activation and accelerating deactivation in a manner specific to KCNQ1 among the channels tested (PMID:12324418); it also suppresses the KCNQ1/KCNE1 (IKs) current in a concentration-dependent manner (PMID:18313602). Beyond KCNQ1, KCNE5 modulates the transient outward current carried by Kv4.3 (KCND3) (PMID:21493962) and reduces KV2.1 surface expression, co-localizing with KV2.1 at intercalated discs in native myocytes and in intracellular vesicles in cell lines, consistent with promotion of intracellular sequestration; Kcne5 deletion in mouse ventricle increases KV1.5, KV4, and KV2.1 current densities (PMID:30289750). Disease-associated variants disrupt these regulatory roles: the atrial-fibrillation-linked KCNE5-L65F abolishes IKs suppression to produce a gain of function (PMID:18313602) and negatively shifts and amplifies KV2.1 current (PMID:30289750), while the variants Y81H and p.[D92E;E93X] increase Kv4.3-mediated Ito as a gain of function (PMID:21493962), mechanistically linking KCNE5 dysfunction to atrial fibrillation and Brugada syndrome.

1. 2002 High

   Established that KCNE5 is a channel-modulating subunit by showing it binds KCNQ1 and imposes an extreme positive shift in voltage-dependent activation through defined transmembrane residues, defining its core biophysical mechanism and channel selectivity.

   Evidence Heterologous co-expression patch-clamp with transmembrane-domain mutagenesis and a channel specificity panel

   PMID:12324418

   Open questions at the time

   • No structural model of the KCNE5-KCNQ1 interface
   • Physiological significance of a >140 mV shift in native tissue not addressed
   • Whether KCNE5 modulates channels beyond the KCNQ/hERG panel not tested here
2. 2008 High

   Connected KCNE5 function to arrhythmia by demonstrating it suppresses IKs and that the AF-associated L65F mutation abolishes this suppression, providing a gain-of-function mechanism for disease.

   Evidence Transient transfection of CHO cells with KCNQ1+KCNE1 plus wild-type or L65F KCNE5; whole-cell patch-clamp

   PMID:18313602

   Open questions at the time

   • Single focused study without native-tissue confirmation
   • Mechanism by which L65F loses suppression not resolved at the residue level
3. 2011 High

   Broadened KCNE5's alpha-subunit repertoire by showing it modulates Kv4.3-mediated Ito and that distinct disease variants (Y81H, D92E;E93X) cause gain-of-function selectively through Kv4.3 rather than KCNQ1.

   Evidence Co-transfection of heterologous cells with KCND3 or KCNQ1 plus mutant KCNE5; patch-clamp with action potential simulation

   PMID:21493962

   Open questions at the time

   • No direct biochemical demonstration of KCNE5-Kv4.3 physical interaction
   • Native myocyte validation of variant effects on Ito not performed
4. 2018 High

   Provided in vivo and trafficking-level mechanism by showing Kcne5 deletion augments multiple ventricular KV currents and that KCNE5 controls KV2.1 surface expression via intracellular sequestration, with the L65F mutant altering KV2.1 gating and amplitude.

   Evidence Kcne5 knockout mouse with intracardiac ECG and myocyte patch-clamp; co-immunofluorescence of KCNE5 and KV2.1; heterologous expression of human mutants

   PMID:30289750

   Open questions at the time

   • Molecular machinery of KCNE5-mediated KV2.1 retention not defined
   • Mouse-to-human extrapolation of KV current repertoire uncertain
   • Whether intracellular co-localization reflects direct binding versus shared trafficking unresolved
5. 2012 Low

   Reported KCNE5 protein expression outside the heart, localizing it to first-trimester placental syncytiotrophoblast, raising the possibility of a non-cardiac role.

   Evidence Immunohistochemistry and qRT-PCR on first-trimester human placental tissue

   PMID:26105295

   Open questions at the time

   • Single localization study with no functional consequence established
   • No mechanistic follow-up or channel partner identified in placenta

• The structural basis of KCNE5 selectivity across its alpha-subunit partners and the trafficking machinery it engages to sequester KV2.1 remain undefined.
• No structure of KCNE5 bound to any alpha-subunit
• Mechanism of KV2.1 intracellular retention unknown
• Non-cardiac (e.g. placental) function uncharacterized